| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10308565 | Seizure | 2012 | 4 Pages |
Abstract
LCM is a useful adjunct in refractory NCSE. The IV formulation allows prompt administration in the intensive care unit setting. Response was seen especially in focal SE. Similar to other AEDs, response was poor in patients with postanoxic injury. Our data is limited by the small number of patients. Larger controlled studies are necessary to assess accurately the efficacy of IV LCM as an early treatment of SE.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
L. Mnatsakanyan, J.M. Chung, E.I. Tsimerinov, D.S. Eliashiv,